Research location
Xi’an
Shanxi, China
Advertisement
Research activity in Xi’an
Shanxi, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 222 trials and 260 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Xi’an
222 linked trials · page 1 of 5A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)NCT07622186 · 2026-07-15 · 1 site observation
RECRUITING
Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLDNCT07632677 · 2026-05-15 · 1 site observation
RECRUITING
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07464587 · 2026-04-14 · 1 site observation
RECRUITING
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)NCT07354061 · 2026-03-25 · 1 site observation
RECRUITING
HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure ManagementNCT07402239 · 2026-03-16 · 1 site observation
RECRUITING
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionNCT07367529 · 2026-02-26 · 1 site observation
RECRUITING
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes MellitusNCT07303803 · 2026-01-01 · 1 site observation
RECRUITING
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and GlecirasibNCT07164170 · 2025-09-22 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT07292714 · 2025-07-15 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT07010263 · 2025-06-13 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary HypertensionNCT07051811 · 2025-02-25 · 1 site observation
RECRUITING
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer PatientsNCT06564324 · 2024-11-27 · 1 site observation
RECRUITING
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast CancerNCT06452706 · 2024-11-14 · 1 site observation
RECRUITING
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationNCT06416410 · 2024-08-07 · 1 site observation
RECRUITING
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119NCT06504290 · 2024-07-16 · 1 site observation
RECRUITING
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate CancerNCT06575257 · 2024-05-01 · 1 site observation
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation
RECRUITING
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsNCT05956587 · 2024-01-29 · 1 site observation
RECRUITING
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC PatientsNCT06155084 · 2023-12-26 · 1 site observation
RECRUITING
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 1 site observation
RECRUITING
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast CancerNCT05860465 · 2023-09-08 · 1 site observation
RECRUITING
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseNCT05908695 · 2023-08-31 · 2 site observations
RECRUITING
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsNCT05914116 · 2023-08-17 · 1 site observation
RECRUITING
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)NCT05909332 · 2023-06-20 · 1 site observation
RECRUITING
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)NCT05891093 · 2023-06-01 · 1 site observation
RECRUITING
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating HypertensionNCT05590871 · 2023-03-31 · 1 site observation
RECRUITING
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1NCT05276726 · 2022-08-17 · 1 site observation
RECRUITING
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast CancerNCT04790305 · 2021-06-18 · 1 site observation
RECRUITING
The Chinese Familial Alzheimer's NetworkNCT03657732 · 2005-01-10 · 2 site observations
RECRUITING
China Cognition and Aging StudyNCT03653156 · 2000-01-01 · 2 site observations
RECRUITING
A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast CancerNCT07782086 · 2026-09-07 · 1 site observation
NOT_YET_RECRUITING
A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNCT07732309 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
SMP-656 for HER2-Positive Advanced Breast CancerNCT07726342 · 2026-07-16 · 1 site observation
NOT_YET_RECRUITING
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEFNCT07687212 · 2026-07-01 · 1 site observation
NOT_YET_RECRUITING
Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled TrialNCT07628777 · 2026-06-01 · 1 site observation
NOT_YET_RECRUITING
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)NCT07230119 · 2026-01-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Left Ventricular Myocardial Work for Predicting Response to CRTNCT07319065 · 2026-01-01 · 2 site observations
NOT_YET_RECRUITING
Efficacy and Safety of ZT006 in Overweight and Obese ParticipantsNCT07230132 · 2025-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsNCT07160335 · 2025-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLCNCT07086326 · 2025-07-31 · 1 site observation
NOT_YET_RECRUITING
Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled TrialNCT06788743 · 2025-06-01 · 1 site observation
COMPLETED
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskNCT07010588 · 2025-06-01 · 1 site observation
NOT_YET_RECRUITING
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.NCT06885840 · 2025-03-31 · 1 site observation
NOT_YET_RECRUITING
A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06789289 · 2025-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast CancerNCT06702618 · 2025-02-20 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase II Study to Evaluate NH102 for DepressionNCT06842992 · 2024-12-04 · 1 site observation
COMPLETED
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).NCT06606509 · 2024-11-07 · 2 site observations
NOT_YET_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.